AAAAAA

   
Results: 1-7 |
Results: 7
RESPONSE AT 3 MONTHS IS A GOOD PREDICTIVE FACTOR FOR NEWLY-DIAGNOSED CHRONIC MYELOID-LEUKEMIA PATIENTS TREATED BY RECOMBINANT INTERFERON-ALPHA
Authors: MAHON FX FABERES C PUEYO S CONYMAKHOUL P SALMI R BOIRON JM MARIT G BILHOUNABERA C CARRERE A MONTASTRUC M PIGNEUX A BERNARD P REIFFERS J
Citation: Fx. Mahon et al., RESPONSE AT 3 MONTHS IS A GOOD PREDICTIVE FACTOR FOR NEWLY-DIAGNOSED CHRONIC MYELOID-LEUKEMIA PATIENTS TREATED BY RECOMBINANT INTERFERON-ALPHA, Blood, 92(11), 1998, pp. 4059-4065
SURVIVAL AFTER AIDS-DEFINING EVENTS IN PATIENTS WITH LESS-THAN-200 LYMPHOCYTES CD4+X10(6) L WHO ARE TOXOPLASMOSIS ANTIBODY-POSITIVE/
Authors: PUEYO S SALMI LR CHENE G LEPORT C MORLAT P DEQUAE L GREGOIRE V HAFNER R VILDE JL LUFT BJ AUBERTIN J SALAMON R
Citation: S. Pueyo et al., SURVIVAL AFTER AIDS-DEFINING EVENTS IN PATIENTS WITH LESS-THAN-200 LYMPHOCYTES CD4+X10(6) L WHO ARE TOXOPLASMOSIS ANTIBODY-POSITIVE/, Journal of acquired immune deficiency syndromes and human retrovirology, 14(5), 1997, pp. 459-464
INCREASED RISK OF TOXOPLASMIC ENCEPHALITIS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS WITH PYRIMETHAMINE-RELATED RASH
Authors: ROUSSEAU F PUEYO S MORLAT P HAFNER R CHENE G LEPORT C LUFT BJ MIRO J AUBERTIN J SALAMON R VILDE JL
Citation: F. Rousseau et al., INCREASED RISK OF TOXOPLASMIC ENCEPHALITIS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS WITH PYRIMETHAMINE-RELATED RASH, Clinical infectious diseases, 24(3), 1997, pp. 396-402
THE STUDY OF CHAOTIC DYNAMICS BY MEANS OF VERY SHORT-TIME SERIES
Authors: PUEYO S
Citation: S. Pueyo, THE STUDY OF CHAOTIC DYNAMICS BY MEANS OF VERY SHORT-TIME SERIES, Physica. D, 106(1-2), 1997, pp. 57-65
PREDICTIVE VALUE OF TOXOPLASMA-GONDII ANTIBODY-TITERS ON THE OCCURRENCE OF TOXOPLASMIC ENCEPHALITIS IN HIV-INFECTED PATIENTS
Authors: DEROUIN F LEPORT C PUEYO S MORLAT P ECOBICHON JL LETRILLART B CHENE G LUFT B AUBERTIN J HAFNER R VILDE JL SALAMON R
Citation: F. Derouin et al., PREDICTIVE VALUE OF TOXOPLASMA-GONDII ANTIBODY-TITERS ON THE OCCURRENCE OF TOXOPLASMIC ENCEPHALITIS IN HIV-INFECTED PATIENTS, AIDS, 10(13), 1996, pp. 1521-1527
PYRIMETHAMINE FOR PRIMARY PROPHYLAXIS OF TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A DOUBLE-BLIND,RANDOMIZED TRIAL
Authors: LEPORT C CHENE G MORLAT P LUFT BJ ROUSSEAU F PUEYO S HAFNER R MIRO J AUBERTIN J SALAMON R VILDE JL BLANC AP SCHMITT JL ARLAUD J ESTAVOYER JM GUILLEVIN L BENTATA M BEYLOT J LACUT JY GRANIER P COSNARD F BAZIN C DORMONT J REY M DELAUNAY C TROISVALLET D MICOUD M WEINBRECK P TREPO C GALLAIS H GASTAUT JA ALLARD C JANBON F CANTON P GROLLEAU JY CASSUTO J DELLAMONICA P DURET P FROTTIER J HERSON S SELIGMANN M SERENI D GIRAUDON BB DIEN G RUEL M STORCK D JAUBERT D LAFEUILLADE A MOUTON Y CHOUTET P LAFAIX C GATELL JM GUELAR A MILDVAN D SOIERO R JACOBSON JM MURRAY HW STEIGBIGEL NH SACHS HH VALENTINE F GRIECO MH ARMSTRONG D LEDERMAN M BARTLETT JA WASKIN HA NICHOLAS P FESSEL JW MACARTHUR RD GLATT AE PHAIR JP POWDERLY W HEWITT R STEIGBIGEL RT BLAIR DC SKAHAN KJ FRAME P CHEESEMAN SH CONNOR EM BALFOUR HH VANDERHORST C HO M
Citation: C. Leport et al., PYRIMETHAMINE FOR PRIMARY PROPHYLAXIS OF TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A DOUBLE-BLIND,RANDOMIZED TRIAL, The Journal of infectious diseases, 173(1), 1996, pp. 91-97
RISK-FACTORS FOR CEREBRAL TOXOPLASMOSIS I N PATIENTS WITH HIV-INFECTIONS - DATA ON A PRIMARY-PROPHYLAXIS TRIAL
Authors: PUEYO S LEPORT C CHENE G MORLAT P HAFNER R VILDE JL LUFT B SALAMON R AUBERTIN J
Citation: S. Pueyo et al., RISK-FACTORS FOR CEREBRAL TOXOPLASMOSIS I N PATIENTS WITH HIV-INFECTIONS - DATA ON A PRIMARY-PROPHYLAXIS TRIAL, La Revue de medecine interne, 14(10), 1993, pp. 1001-1001
Risultati: 1-7 |